This Solicitation opportunity from Department Of Defense was posted on May 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
CLOBETASOL PROPIONA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract solicitation SPE2DP-26-T-3383 is for the procurement of Clobetasol Propionate Cream 0.05% in 15 gm tubes, identified by NSN 6505-01-229-9098, with a requirement for 10 tubes under the unit of issue TU, where one TU equals three individual tubes. The item is regulated by the FDA and must be supplied in compliance with strict medical packaging and labeling standards, with Medical Marking Standard No. 1 superseding MIL-STD-129. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier, with palletization adhering to DLA Packaging Requirements for Procurement (RP001). The product has a non-extendable 18-month shelf life under TYPE I CODE K requirements, and all packaging must meet commercial standards as defined by ASTM D3951 for non-hazardous materials or TQ requirement IP025 if deemed hazardous under FED-STD-313. Delivery is FOB destination to the address in Baumholder, Germany, with a mandatory delivery window of 10 days after award, targeting May 14, 2026. Inspection and acceptance occur at the point of delivery, and invoicing must be submitted through Wide Area WorkFlow. The contract explicitly references multiple FAR and DFARS clauses governing acquisition processes, including Equal Opportunity, Combating Trafficking, Employment Eligibility Verification, Sustainable Products, Hazardous Material Identification, and Disclosure of Information. Offerors are required to comply with cybersecurity standards under NIST SP 800-171 and DFARS 252.204-7012, including system assessments reported to the Supplier Performance Risk System and flow-down obligations to subcontractors. Entity identification via Unique Entity ID and CAGE Code is mandatory, and socioeconomic status representations must be current, including any claimed small business, SDVOSB, HUBZone, or WOSB certifications. Pricing fields remain unfilled in the contract, and the type of contract to be awarded is unspecified pending contracting officer determination. The solicitation is open for responses through the DIBBS portal until May 18, 2026, with procurement administered by the Department of Defense under the Medical Supply Chain Pharm FSA, and primary point of contact for the contracting officer is Imerah Burnett
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
CLOBETASOL PROPIONATE CREAM,0.05%,15 GM TUBE
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
GLAXO SMITH KLINE "TEMOVATE" NDC00173-0375-73
TEVA PHARM NDC51672-1258-01
AAC L; U/I "TU" (15 GM)
MGAC, LFLYNN 06054
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 TU = 3 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-3383
SECTION B
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
AVKARE LLC 4QGW8 P/N NDC42291-0076-15 TARO PHARMACEUTICALS U.S.A., INC. 3HFB6 P/N NDC51622-1258-01 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC51672-1258-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016748442 0001 TU 10.000
NSN/MATERIAL:6505012299098
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF3
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
W50YF3
SPE2DP-26-T-3383
SECTION B
PR: 7016748442 PRLI: 0001 CONT’D
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
MARKFOR
W50YF3
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
M/F: (TCN) W50YF361310009
RDD: 143
PROJ: 9GU TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/14/2026
SPE2DP-26-T-3383 NSN/Part Number: 6505-01-229-9098 Quantity: 10 TU Purchase Request: 7016748442QTY: 10 Delivery: 10 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS